Women in clinical trials of new drugs. A change in Food and Drug Administration policy. The Working Group on Women in Clinical Trials.

The Food and Drug Administration (FDA) is taking two important steps to ensure that new drugs are properly evaluated in women. First, it is providing formal guidance to drug developers to emphasize its expectations that women will be appropriately represented in clinical studies and that new drug applications will include analyses capable of identifying potential differences in drug actions or efficacy between the sexes. Second, the agency is altering a 16-year-old policy that has excluded most women with “childbearing potential” from the earliest phases of clinical trials. Attention to sex differences is part of a larger effort by the FDA . . .

[1]  T. Johnson.  Position Paper: A Women's Health Research Agenda , 1993 .

[2]  W. Ray,et al.  Pregnancy Outcome Following Exposure to Angiotensin‐Converting Enzyme Inhibitors , 1992, Obstetrics and gynecology.

[3]  M. Diamond,et al.  Alterations in Glucose Metabolism During Menstrual Cycle in Women With IDDM , 1992, Diabetes Care.

[4]  J. Powell,et al.  Age and gender effects on ondansetron pharmacokinetics: Evaluation of healthy aged volunteers , 1992, Clinical pharmacology and therapeutics.

[5]  R. Kirschstein.  Research on women's health. , 1991, American journal of public health.

[6]  G. Shenfield,et al.  Clinical Pharmacokinetics of Contraceptive Steroids An Update , 1991, Clinical pharmacokinetics.

[7]  W. Hooper,et al.  The influence of age and gender on the stereoselective metabolism and pharmacokinetics of mephobarbital in humans , 1990, Clinical pharmacology and therapeutics.

[8]  C. Lieber,et al.  High blood alcohol levels in women. The role of decreased gastric alcohol dehydrogenase activity and first-pass metabolism. , 1990, The New England journal of medicine.

[9]  T. Walle,et al.  Pathway‐selective sex differences in the metabolic clearance of propranolol in human subjects , 1989, Clinical pharmacology and therapeutics.

[10]  D. Kessler,et al.  The regulation of investigational drugs. , 1989, The New England journal of medicine.

[11]  Nafziger An,et al.  Sex-related differences in theophylline pharmacokinetics. , 1989 .

[12]  R Temple.  The clinical investigation of drugs for use by the elderly: Food and Drug guidelines , 1987, Clinical pharmacology and therapeutics.

[13]  J. Miners,et al.  Influence of gender and oral contraceptive steroids on the metabolism of salicylic acid and acetylsalicylic acid. , 1986, British journal of clinical pharmacology.

[14]  L. Benet,et al.  Impairment of prednisolone disposition in women taking oral contraceptives or conjugated estrogens. , 1986, The Journal of clinical endocrinology and metabolism.

[15]  J. Hamilton.  An overview of the clinical rationale for advancing gender-related psychopharmacology and drug abuse research. , 1986, NIDA research monograph.

[16]  M. Arthur,et al.  Sex differences in the metabolism of ethanol and acetaldehyde in normal subjects. , 1984, Clinical science.

[17]  J. Miners,et al.  Lidocaine disposition—Sex differences and effects of cimetidine , 1984, Clinical pharmacology and therapeutics.

[18]  Neil Massoud,et al.  Pharmacokinetic Basis for Drug Treatment , 1984 .

[19]  A. Breckenridge,et al.  Clinical Pharmacokinetics of Oral Contraceptive Steroids , 1983, Clinical pharmacokinetics.

[20]  D. Greenblatt,et al.  Obesity, sex, and acetaminophen disposition , 1982, Clinical pharmacology and therapeutics.

[21]  D. Greenblatt,et al.  Effect of age and gender on disposition of temazepam. , 1981, Journal of pharmaceutical sciences.

[22]  R. Lauro,et al.  Differences in insulin receptors between men and menstruating women and influence of sex hormones on insulin binding during the menstrual cycle. , 1980, The Journal of clinical endocrinology and metabolism.

[23]  A. Herbst,et al.  Adenocarcinoma of the vagina. Association of maternal stilbestrol therapy with tumor appearance in young women. , 1971, The New England journal of medicine.

[24]  R. Scully,et al.  Adenocarcinoma of the vagina in adolescence. A report of 7 cases including 6 clear‐cell carcinomas (so‐called mesonephromas) , 1970 .